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Background: Influenza H7N9 has become an endemic pathogen in China where circulating virus is found
extensively in wild birds and domestic poultry. Two epidemic waves of Human H7N9 infections have taken place in
Eastern and South Central China during the years of 2013 and 2014. In this study, we report on the first four human
cases of influenza H7N9 in Shantou, Guangdong province, which occurred during the second H7N9 wave, and the
subsequent analysis of the viral isolates.
Methods: Viral genomes were subjected to multisegment amplification and sequenced in an Illumina MiSeq. Later,
phylogenetic analyses of influenza H7N9 viruses were performed to establish the evolutionary context of the
disease in humans.
Results: The sequences of the isolates from Shantou have closer evolutionary proximity to the predominant Eastern
H7N9 cluster (similar to A/Shanghai/1/2013 (H7N9)) than to the Southern H7N9 cluster (similar to A/Guangdong/1/2013
(H7N9)).
Conclusions: Two distinct phylogenetic groups of influenza H7N9 circulate currently in China and cause infections in
humans as a consequence of cross-species spillover from the avian disease. The Eastern cluster, which includes the four
isolates from Shantou, presents a wide geographic distribution and overlaps with the more restricted area of circulation
of the Southern cluster. Continued monitoring of the avian disease is of critical importance to better understand and
predict the epidemiological behaviour of the human cases.Background
A novel influenza H7N9 virus (A/Shanghai/1/2013 (H7N9)
and related isolates) emerged in China in March of 2013,
causing 32 reported deaths by May 30 and a case fatality
rate of 25% [1]. After the first series of human cases in
Shanghai [2], the outbreak spread to multiple provinces of
Eastern China although the majority of cases were detected
in the eastern provinces of Jiangsu, Shanghai and Zhejiang
(Figure 1A-B). This new virus originated as a result of gene
reassortments from other circulating avian influenza viruses
from the H7N7 and H7N9 subtypes [3]. Circulation of the* Correspondence: dkelvin@jidc.org
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ported in affected regions, and most human cases had a his-
tory of poultry contact [4-7]. This evidence suggests a
zoonotic origin for the human H7N9 disease. Interest-
ingly, viral surveillance revealed circulation of H7N9 in
poultry markets in the southern province of Guangdong
but without causing human disease [8], indicating that
the presence of the H7N9 virus in a region did not sys-
tematically lead to human disease, or was possibly
under-diagnosed.
A new variant of H7N9 (A/Guangdong/1/2013 (H7N9)
and related isolates) was first detected in humans in Au-
gust 2013 and caused a number of infections in humans in
Guangdong and Hong Kong during the months following
the initial outbreak (Figure 1C). This new variant was also
the result of gene reassortment, with genes originating
from avian influenza strains that were circulating in the
South of China [8,9]. Later, a second wave of human casesal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Temporal, geographic and genetic distribution of human cases of influenza H7N9. A) Evolution in the number of reported
influenza H7N9 infections in humans caused by viruses from the Eastern cluster (similar to A/Shanghai/1/2013(H7N9) and the Southern cluster
(similar to A/Guangdong/1/2013(H7N9)). B) and C) Geographic distribution of human cases during the first and second waves of the disease,
respectively. The number of cases and their locations were obtained from the WHO case reports on influenza H7N9 (http://www.wpro.who.int/
outbreaks_emergencies/H7N9.archive/en/). The genetic classification of the H7N9 clusters is based on the phylogenetic analysis of the viral
isolates. Shaded areas represent the territories in which the presence of the virus has been detected by surveillance studies.
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after September 2013 and affected the Eastern and Southern
provinces of China. Environmental surveillance data
and epidemiological reports revealed that influenza H7N9
had achieved the status of a circulating strain among avian
species and causing human disease as a consequence of
sustained cross-species spillover [10].
Here we analyzed the genomic sequences of four
influenza H7N9 viruses that were isolated in Shantou
(Guangdong province, People’s Republic of China) during




Four patients with no apparent epidemiological relationship
were admitted to the ICU unit of the Shantou Central
Hospital and the ICU unit of the First Affiliated Hospital
of Shantou University Medical College in Shantou
(Guangdong province, People’s Republic of China) in March
and April 2014. The patients presented influenza-like
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pneumonia that developed into acute respiratory distress
syndrome (ARDS). Two of the patients (#1 and #4) died
due to irreversible deterioration of their clinical status, and
the other two (#2 and #3) fully recovered. Upon admission,
lung aspirates were collected through a suction catheter
inserted into the endotracheal tube. A first analysis of the
samples performed by China CDC confirmed the presence
of influenza H7N9. A complete description of the clinical
findings is to be published as part of a separate manuscript.
This study was approved by the Ethics Committee of the
Shantou Central Hospital and by the Ethics Committee of
the First Affiliated Hospital of Shantou University Medical
College. Each patient provided written informed consent.
Virus isolation and sequencing
Lung aspirates were cleared by centrifugation and inoc-
ulated into chicken eggs for viral growth. Total RNA
was extracted from 100 μl of allantoic fluid using Trizol
LS (Life Technologies) according to the manufacturer’s
protocol. Complete viral genomes were amplified by
multisegment reverse-transcription PCR (M-RTPCR), a
method that allows simultaneous amplification of all
viral segments by using a pair of universal primers targeted
against highly conserved flanking regions, as previously
described [11]. Briefly, RNA was subjected to reverse
transcription and PCR amplification with the SuperScript
III One-Step RT-PCR System (Life Technologies), using
the primers MBTuni12-ACGCGTGATCAGCAAAAGCAGG
and MBTuni13-ACGCGTGATCAGTAGAAACAAGG and
the following thermal cycler program: 42°C for 60 min
and 94°C for 2 min; 5 cycles of 94°C for 30 sec, 45°C for
30 sec and 68°C for 3 min; 31 cycles of 94°C for 30 sec,
57°C for 30 sec and 68°C for 3 min. Sequencing libraries
were prepared by using the Nextera XT DNA Sample
Preparation kit (Illumina) according to the manufacturer’s
protocol, and 150 bp paired-end sequencing was per-
formed in a MiSeq instrument (Illumina). The resulting
short reads were aligned with respect to the sequences of
A/Shanghai/1/2013 (H7N9) by Bowtie2 (2.2.3) [12] and
the consensus sequences were generated with SAMtools
(1.0) [13], as previously described [14]. The sequence variants
were called with VarScan (2.3.6) [15] and only considered if
causing aminoacid substitution and with a frequency ≥2%.
Phylogenetic analyses
To establish the evolutionary context of the isolates from
Shantou, phylogenetic analyses with the published H7N9
nucleotide sequences were performed. The genomic se-
quences of H7N9 isolates were retrieved from in GISAID’s
EpiFlu database as of December 31st 2014. Isolates were
grouped according to their collection date as follows: first
wave (February 1st to June 30th, 2013), and second wave
(July 1st 2013 to June 30th 2014). Only those isolates forwhich all their eight genomic segments were available with
at least 75% of coverage were included in the analyses. In
total, the genomic sequences from 95 human isolates were
used in the analysis, including the Shantou strains. Add-
itionally, 6 avian isolates and 4 environmental isolates that
are representative of the core genetic groups and of the dif-
ferent reassortant sub-groups were included in the analysis
(Additional file 1: Table S1). MEGA6 (v6.0.6) [16] was used
to infer the evolutionary history for each viral segment
by using the Maximum Likelihood method based on
the General Time Reversible Model [17] and using 1000
bootstrap replications.
Results
Sequencing of four influenza H7N9 isolates of human
origin
In this study, four influenza H7N9 viruses that were iso-
lated from patients with severe pneumonia in Shantou
during March and April of 2014 were characterized at
the genomic level. The clinical specimens collected from
these patients were inoculated into embryonated eggs
for viral expansion and the resulting isolates were named
A/Shantou/1001/2014 (H7N9), A/Shantou/1002/2014
(H7N9), A/Shantou/1003/2014 (H7N9) and A/Shantou/
1004/2014 (H7N9). After amplification of the viral ge-
nomes by M-RTPCR, the sequencing of the PCR prod-
ucts resulted in approximately 184,000, 248,000, 214,000
and 192,000 viral short-reads, respectively. The resulting
consensus sequences presented complete coverage of the
viral genomes and they were deposited on GISAID’s
EpiFlu database (isolate identifiers EPI_ISL_162618,
EPI_ISL_162619, EPI_ISL_162620 and EPI_ISL_162621,
respectively).
The isolates from Shantou belong to the Eastern cluster
of influenza H7N9
Next, we sought to characterise the evolutionary context
of the human disease. The phylogenetic analyses of the
viral genes indicate that, despite the presence of reassor-
tant groups, all the strains of the first wave of the disease
share a common evolutionary history and they do not
form apparent clusters by host species (Figure 2). A sep-
arate set of phylogenetic analyses that included the hu-
man isolates (n = 95), and the available avian (n = 44)
and environmental (n = 21) isolates, also indicate that
the strains are evenly distributed across reassortant
groups regardless of their origin (data not shown). The
strains of the second wave are divided between a first
group whose gene sequences clustered together with the
strains of the first wave, and a second group in which a
majority of their genes (PB2, PB1, PA, NP and NS)
formed separate clusters with an evolutionary history in-
dependent from the rest of the H7N9 strains. Therefore,
we defined one first phylogenetic group of H7N9 strains
Figure 2 (See legend on next page.)
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Figure 2 Phylogenetic analysis of the viral segments of influenza H7N9 isolated from human patients. Using the software program Mega
6.02, phylogenetic trees were inferred by using the Maximum Likelihood method based on the General Time Reversible Model with 1000
bootstrap replications. Bootstrap support values ≥70% are shown. Branch lengths are proportional to number of substitutions per site. Unmarked
strain names: Eastern cluster from the first wave of the disease; blue circle: Eastern cluster from the second wave of the disease; red circle:
Southern cluster from the second wave of the disease; Yellow highlight: viral isolates from Shantou; blue highlight: strain of avian or
environmental origin.
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2013 and related strains in which the Shantou strains
are included; we also defined a second group of H7N9
strains named the Southern cluster that includes
A/Guangdong/1/2013 and related strains. Although both
A/Shanghai/1/2013 and A/Guangdong/1/2013 carry
reassortments that set them apart from their respective
core groups (as shown in Figures 2 and 3), they are men-
tioned as representative of the Eastern and Southern
clusters, respectively, for historical reasons and because
of their higher relevance in the related literature.
The variability within the human isolates of the
Eastern cluster is mainly caused by gene reassortments
that led to the formation of groups of strains that in-
clude MP-R1, the double reassortment PB1-R1&NP-R1,
and PB2-R1. Within the Southern cluster, a group
of strains carry the PA gene of the Eastern cluster
(PA-Eastern subgroup), possibly as a late re-introduction
(Figures 2 and 3). The gene reassortments found in the
human isolates of the Eastern cluster were also present
in the avian and environmental isolates; unfortunately,
no complete genomic sequences of avian or environ-
mental samples belonging to the Southern cluster wereFigure 3 Genetic make-up of the sub-groups of human isolates of influ
and the phylogenetic origin of their genomic segments is shown by the coloavailable as of this writing and precluded us from per-
forming a direct comparison of strains of different origin
within this group.
Aminoacid substitutions in the proteins of the Shantou
strains
At the aminoacid level, several novel substitutions were
present in all four Shantou strains (Additional file 2:
Table S2): PA (P271S and N321C), HA (E409G [H3
numbering]), M2 (V27I), NA (S78N and R220Q [both in
N2 numbering]) and NS1 (S48I and A82P). Mapping the
aminoacid substitutions to the 3D structures of the HA
and NA genes (PDB accessions 4KOL and 4MWL, re-
spectively) showed that HA-E409G belongs to the stalk
domain of the HA2 protein, NA-S78N belongs to the
stalk domain of the NA protein, and NA-R220Q is situ-
ated in an area of the NA protein surface not related to
the active site (Figure 4).
A number of substitutions were detectable only in
part of the short-read sequences and coexisted with the
reference version; this is an indication of the presence
of viral quasi-species carrying different versions of the
protein (Additional file 2: Table S2). None of theenza H7N9. For each group, two representative strains were selected,
ur code indicated in the panel.
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matched the characteristic traits of the Southern clus-
ter, ruling out the presence of those variant genes even
at low concentration.
Nonetheless, the pathogenic implications of these ami-
noacid substitutions, if any, are presently unknown and
would require further investigation.
Discussion
Although it was shown that H7N9 virus has the cap-
acity to adapt to mammalian hosts [18,19], forFigure 4 Mapping of aminoacid substitutions found in the hemagglu
four Shantou isolates. Ribbon diagrams were generated with Pymol (1.7.1
Protein Workshop (http://www.rcsb.org) using PDB accessions 4KOL (HA) amammal-to-mammal transmission [20] and limited
human-to-human transmission [7], there is, to date, lit-
tle supporting evidence that any mammal-adapted
strain has achieved sustained circulation. The fact that
no species-specific clusters are detected in the phylo-
genetic analyses supports the idea that the isolates from
human cases have arisen directly from the pool of
H7N9 avian viruses that are circulating in each loca-
tion. Genetic tuning of the virus through the incorpor-
ation of specific nucleotide substitutions and gene
reassortments are responsible for modulating the viraltinin A) and neuraminidase B) proteins that are present in the
.13) (http://www.pymol.org) and the 3D protein structures with RCSB’s
nd 4MWL (NA).
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different host species [9,21,22]. It is likely that the
spectrum of circulating avian H7N9 strains is broader
than the one observed in the human isolates due to the
presence of sub-groups with lower capacity for causing
human infections.
Newly emerged influenza H7N9 has been circulating
among avian species in different provinces of China
since early 2013 and causing severe infections in
humans. The four human cases of influenza H7N9 from
Shantou were severe infections that caused death in two
of the patients. The isolated viruses belong to the
Eastern cluster, which is the predominant phylogenetic
group among H7N9 viruses with wide distribution
across multiple provinces of China (Figure 1B-C). Phylo-
genetic analyses show that the Shantou isolates derive
from a common ancestor without having undergone
gene reassortments or major evolutionary changes due
to antigenic drifting. These results indicate that these
four viruses, which were isolated within the short period
of just two months, all derive from the same local pool
of influenza H7N9 strains that were circulating among
avian species at that time.
Human infections with viruses from the Southern
cluster started during the second wave of the disease
[10]. The phylogenetic analyses of their segments reveal
that the NP and NS genes [8], as well as the PB2, PB1
and PA genes, are part of a separate lineage, whereas
their HA, NA and MP genes have the same phylogenetic
history as the Eastern cluster (Figure 2). Surveillance stud-
ies performed in isolates from avian and environmental
samples, and from human cases in the Guangdong prov-
ince, showed sustained co-circulation of strains from the
Eastern and Southern clusters in some areas [10]. Al-
though gene reassortments between these two groups of
viruses are possible, as shown by the incorporation of the
PA-Eastern gene in several strains of the Southern cluster
(Figures 2 and 3), both clusters have remained largely in-
dependent despite being co-circulating in those some
areas. Nonetheless, the full extent of the geographical and
host species distribution of the different H7N9 sub-groups
will be established more precisely through additional mon-
itoring of avian influenza.
Conclusions
So far, circulation of viruses from both the Eastern and
Southern clusters of influenza H7N9 is restricted to
avian hosts. We found that the genetic differences be-
tween these two clusters are concentrated in the in-
ternal genes, which may be a consequence of distinct
profiles of viral fitness and transmission capacity on dif-
ferent avian species. Therefore, the geographical distri-
bution of the H7N9 clusters may be a direct
consequence of the geographical distribution of theirpreferred hosts. Continued monitoring efforts of the
avian disease and host specificity studies are necessary to
further understand the avian disease and its impact on the
human population.
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